TrialThe Lancet. Oncology2010

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.

S Vincent Rajkumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.